bevacizumab-800cw
Showing 1 - 5 of 5
Colon Carcinoma, Barrett Esophagus, Gastrointestinal Dysplasia Trial (Bevacizumab-800CW)
Not yet recruiting
- Colon Carcinoma
- +2 more
- Bevacizumab-800CW
- (no location specified)
Aug 22, 2023
Inverted Papilloma, Molecular Fluorescence Imaging Trial in Groningen (Bevacizumab-800CW)
Active, not recruiting
- Inverted Papilloma
- Molecular Fluorescence Imaging
- Bevacizumab-800CW
-
Groningen, NetherlandsUniversity Medical Center Groningen
Apr 30, 2021
Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Groningen, Leiden, Nijmegen (Bevacizumab-800CW)
Terminated
- Pancreatic Cancer
- Pancreatic Adenocarcinoma
- Bevacizumab-800CW
-
Groningen, Netherlands
- +2 more
Jan 25, 2020
Endometriosis Trial in Groningen (Bevacizumab-800CW)
Unknown status
- Endometriosis
- Bevacizumab-800CW
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jun 26, 2017
Breast Cancer Trial in Groningen (Bevacizumab-800CW)
Completed
- Breast Cancer
- Bevacizumab-800CW
-
Groningen, NetherlandsUniversity Medical Center Groningen
Feb 10, 2017